TW202227433A - 中環或大環之經苄基取代的雜環衍生物及相關用途 - Google Patents
中環或大環之經苄基取代的雜環衍生物及相關用途 Download PDFInfo
- Publication number
- TW202227433A TW202227433A TW110132882A TW110132882A TW202227433A TW 202227433 A TW202227433 A TW 202227433A TW 110132882 A TW110132882 A TW 110132882A TW 110132882 A TW110132882 A TW 110132882A TW 202227433 A TW202227433 A TW 202227433A
- Authority
- TW
- Taiwan
- Prior art keywords
- alkyl
- compound
- alkenyl
- present disclosure
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074220P | 2020-09-03 | 2020-09-03 | |
| US63/074,220 | 2020-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202227433A true TW202227433A (zh) | 2022-07-16 |
Family
ID=78078371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110132882A TW202227433A (zh) | 2020-09-03 | 2021-09-03 | 中環或大環之經苄基取代的雜環衍生物及相關用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230331720A1 (https=) |
| EP (1) | EP4208465A1 (https=) |
| JP (1) | JP7811578B2 (https=) |
| CN (1) | CN116635393A (https=) |
| TW (1) | TW202227433A (https=) |
| WO (1) | WO2022051583A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4065585B1 (en) | 2019-11-25 | 2025-08-20 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| CN116583502A (zh) | 2020-09-03 | 2023-08-11 | 欧瑞夏治疗有限公司 | 二环-杂环衍生物及其作为食欲素-2受体激动剂的用途 |
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| US12006330B2 (en) | 2020-12-21 | 2024-06-11 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| AU2022280804A1 (en) * | 2021-05-26 | 2023-11-30 | Alkermes, Inc. | Substituted carbamate macrocyclic compounds and related methods of treatment |
| JP2025507852A (ja) * | 2022-03-01 | 2025-03-21 | センテッサ ファーマシューティカルズ （ユーケー） リミテッド | 中環状または大環状ベンジル置換複素環誘導体および関連の使用 |
| IL316468A (en) * | 2022-04-22 | 2024-12-01 | Teijin Pharma Ltd | The aftermath of oxazepine |
| CN114716319B (zh) * | 2022-04-28 | 2024-03-26 | 浙江工业大学 | 一种联芳氧基烯酸酯类化合物的合成方法 |
| WO2024075825A1 (ja) * | 2022-10-07 | 2024-04-11 | キッセイ薬品工業株式会社 | シクロペンタン化合物 |
| EP4611745A1 (en) | 2022-10-31 | 2025-09-10 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
| PE20252742A1 (es) | 2023-03-16 | 2025-12-05 | Takeda Pharmaceuticals Co | Compuestos heterociclicos macrociclicos y sus usos |
| IL324946A (en) | 2023-06-01 | 2026-01-01 | H Lundbeck As | Spiro-macrocyclic orexin 2 receptor agonists |
| EP4719397A1 (en) | 2023-06-02 | 2026-04-08 | Takeda Pharmaceutical Company Limited | Use of an orexin 2 receptor agonist for improving respiratory function during sleep |
| TW202535890A (zh) * | 2023-10-20 | 2025-09-16 | 日商帝人製藥股份有限公司 | 氧氮呯衍生物之結晶或其溶劑合物之結晶 |
| WO2025124698A1 (en) | 2023-12-12 | 2025-06-19 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
| TW202542165A (zh) | 2023-12-19 | 2025-11-01 | 瑞士商愛杜西亞製藥有限公司 | 大環食慾素激動劑 |
| WO2025229493A1 (en) | 2024-04-29 | 2025-11-06 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| PE20081229A1 (es) * | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
| US10428023B2 (en) | 2017-08-03 | 2019-10-01 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| JP7253640B2 (ja) * | 2019-01-31 | 2023-04-06 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
| EP4065585B1 (en) * | 2019-11-25 | 2025-08-20 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
-
2021
- 2021-09-03 JP JP2023515095A patent/JP7811578B2/ja active Active
- 2021-09-03 CN CN202180074185.9A patent/CN116635393A/zh active Pending
- 2021-09-03 TW TW110132882A patent/TW202227433A/zh unknown
- 2021-09-03 EP EP21786656.5A patent/EP4208465A1/en active Pending
- 2021-09-03 US US18/024,236 patent/US20230331720A1/en active Pending
- 2021-09-03 WO PCT/US2021/049003 patent/WO2022051583A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN116635393A (zh) | 2023-08-22 |
| WO2022051583A1 (en) | 2022-03-10 |
| EP4208465A1 (en) | 2023-07-12 |
| JP2023540350A (ja) | 2023-09-22 |
| JP7811578B2 (ja) | 2026-02-05 |
| US20230331720A1 (en) | 2023-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW202227433A (zh) | 中環或大環之經苄基取代的雜環衍生物及相關用途 | |
| US12503475B2 (en) | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | |
| TWI881008B (zh) | 嗒基-噻唑甲醯胺化合物 | |
| KR20190005838A (ko) | 이중 lsd1/hdac 억제제로서 사이클로프로필-아마이드 화합물 | |
| TW202003466A (zh) | 人類整合素α４β７拮抗劑 | |
| WO2022207935A1 (en) | 2-(3-ethynylbenzyl)-substituted heterocycle derivatives as orexin-2 agonists | |
| AU2023228830A1 (en) | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses | |
| TW202319043A (zh) | 3,4-亞甲二氧甲基苯丙胺及相關致幻劑及其用途 | |
| CN119156375A (zh) | 双环杂环衍生物和相关用途 | |
| CN106458976A (zh) | 用于治疗疾病诸如糖尿病的吡咯烷gpr40调节剂 | |
| US20070254958A1 (en) | Phenyl Carboxamide Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease | |
| CN114641466B (zh) | 磺酰脲衍生物及其用途 | |
| CN110072859A (zh) | 作为RORγ调节剂的化合物 | |
| CN114761383A (zh) | 磺酰胺衍生物及其用途 | |
| CN111902401B (zh) | 受体抑制剂、包含其的药物组合物及其用途 | |
| EA052303B1 (ru) | Средне- или макроциклические производные бензилзамещенного гетероцикла и связанные с ними применения | |
| CN120202197A (zh) | 一种含氮螺环类化合物、药物组合物以及其用途 | |
| CN117945945A (zh) | 一种gpr139受体激动剂、其制备方法及其应用 | |
| HK1263406A1 (en) | Cyclopropyl-amide compounds as dual lsd1/hdac inhibitors | |
| HK1263406B (zh) | 作为双重lsd1/hdac抑制剂的环丙基-酰胺化合物 |